Skip to main content
SR biotek Inc. logo

SR biotek Inc. — Investor Relations & Filings

Ticker · 270210 ISIN · KR7270210008 KO Manufacturing
Open in API
Filings indexed 190 across all filing types
Latest filing 2022-04-05 Report Publication Anno…
Country KR South Korea
Listing KO 270210

About SR biotek Inc.

http://srbiotek.com/

SR biotek Inc. is a biotechnology and cosmeceutical company specializing in the research, development, and manufacturing of innovative skincare products. The company offers comprehensive turnkey OEM/ODM solutions to its partners, covering product development, quality control, and manufacturing. A core strength lies in the development of novel ingredients, highlighted by its proprietary bio-material, RAPHITOX, which utilizes a micro-needle shaped structure. In addition to its manufacturing services, SR biotek also develops its own branded skincare lines.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves or a transcript of the event, it falls under the category of a regulatory announcement regarding corporate activities.
2022-04-05 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official filing titled '정기주주총회 결과' (Annual General Meeting Results) for the company SR Biotech. It details the outcomes of the meeting held on 2022-03-28, including the approval of financial statements, dividend decisions, and the election of directors. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여). This type of disclosure, which details the issuance of stock options to employees and executives, falls under the category of capital changes or share-related announcements. Since it specifically details the issuance of stock options (a form of equity-based compensation/capital change), it is best classified as a share issue/capital change announcement.
2022-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing (under 5,000 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion and key financial figures, and explicitly states that the audit report has been submitted/received on 2022-03-21. According to the 'Menu vs Meal' rule, this is an announcement of the report's publication rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'SR Biotech' (주식회사 에스알바이오텍) for the fiscal year ending December 31, 2021. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) typically found in a full annual report, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2021
2022-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SR Biotech. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and stock option grants) for the 15th Annual General Meeting. It also includes management reference materials (경영참고사항) regarding business operations, market status, and industry outlook. This document is a standard proxy statement/notice for an upcoming shareholder meeting.
2022-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.